Editorial: Monitoring methotrexate polyglutamates in Crohn's disease-Authors' reply

Aliment Pharmacol Ther. 2024 Jan;59(1):120-121. doi: 10.1111/apt.17795.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Crohn Disease* / diagnosis
  • Crohn Disease* / drug therapy
  • Humans
  • Immunosuppressive Agents
  • Methotrexate / therapeutic use
  • Polyglutamic Acid

Substances

  • methotrexate polyglutamate
  • Methotrexate
  • Immunosuppressive Agents
  • Polyglutamic Acid